First-in-Human (FIH) clinical trials, also known as Phase 1 trials, are a pivotal stage in drug development. Conducted with a small group of healthy volunteers, these studies mark the first testing of a new drug in humans. Given the high stakes and unique challenges, ensuring rigorous management is crucial. At Cyntegrity, we specialize in Risk-Based Quality Management (RBQM) solutions designed to address these complexities effectively.
Jul
2024
Enhancing Phase 1 Trials with Risk-Based Quality Management
The Importance of First-in-Human (FIH) Trials First-in-Human (FIH) clinical trials, also known as Phase 1 trials, are a pivotal stage in drug development. Conducted with a small group of healthy volunteers, these studies mark the first testing of a new drug in humans. [...]
